Group One Trading, L.P. Editas Medicine, Inc. Transaction History

Group One Trading, L.P.

  • $2.4 Billion
  • Q3 2024

A detailed history of Group One Trading, L.P. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 3,422 shares of EDIT stock, worth $8,349. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,422
Holding current value
$8,349
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.39 - $5.96 $11,600 - $20,395
3,422 New
3,422 $11,000
Q4 2022

Feb 09, 2023
BUY
$8.32 - $13.21 $47,914 - $76,076
5,759 Added 29.74%
25,125 $222,000
Q3 2022

Nov 09, 2022
SELL
$12.16 - $19.42 $234,931 - $375,194
-19,320 Reduced 49.94%
19,366 $237,000
Q2 2022

Aug 11, 2022
SELL
$9.99 - $21.35 $567,262 - $1.21 Million
-56,783 Reduced 59.48%
38,686 $458,000
Q1 2022

May 12, 2022
BUY
$14.08 - $27.63 $1.02 Million - $2 Million
72,329 Added 312.57%
95,469 $1.82 Million
Q4 2021

Feb 11, 2022
SELL
$26.55 - $40.57 $310,847 - $474,993
-11,708 Reduced 33.6%
23,140 $614,000
Q3 2021

Nov 12, 2021
SELL
$39.27 - $72.94 $1.7 Million - $3.16 Million
-43,357 Reduced 55.44%
34,848 $1.43 Million
Q2 2021

Aug 10, 2021
SELL
$31.29 - $56.64 $657,027 - $1.19 Million
-20,998 Reduced 21.17%
78,205 $4.43 Million
Q1 2021

May 12, 2021
BUY
$39.71 - $90.58 $3.94 Million - $8.99 Million
99,203 New
99,203 $4.17 Million
Q4 2020

Feb 10, 2021
SELL
$27.07 - $84.35 $352,478 - $1.1 Million
-13,021 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$28.06 - $37.16 $85,077 - $112,669
-3,032 Reduced 18.89%
13,021 $365,000
Q2 2020

Aug 13, 2020
SELL
$18.5 - $34.34 $923,520 - $1.71 Million
-49,920 Reduced 75.67%
16,053 $475,000
Q1 2020

May 13, 2020
BUY
$14.88 - $32.78 $981,678 - $2.16 Million
65,973 New
65,973 $1.31 Million
Q4 2019

Feb 10, 2020
SELL
$19.49 - $32.63 $389,488 - $652,077
-19,984 Closed
0 $0
Q3 2019

Nov 12, 2019
BUY
$22.49 - $26.81 $154,866 - $184,613
6,886 Added 52.57%
19,984 $454,000
Q2 2019

Aug 09, 2019
SELL
$20.48 - $27.76 $601,538 - $815,366
-29,372 Reduced 69.16%
13,098 $324,000
Q1 2019

May 13, 2019
BUY
$19.43 - $26.41 $804,071 - $1.09 Million
41,383 Added 3807.08%
42,470 $1.04 Million
Q4 2018

Feb 06, 2019
BUY
$18.19 - $31.79 $19,772 - $34,555
1,087 New
1,087 $25,000
Q1 2018

May 11, 2018
SELL
$29.84 - $44.08 $363,928 - $537,599
-12,196 Closed
0 $0
Q4 2017

Feb 09, 2018
SELL
$21.89 - $31.34 $267,670 - $383,225
-12,228 Reduced 50.07%
12,196 $375,000
Q3 2017

Nov 15, 2017
SELL
$15.81 - $24.01 $522,678 - $793,770
-33,060 Reduced 57.51%
24,424 $586,000
Q2 2017

Aug 14, 2017
BUY
N/A
57,484
57,484 $965,000

Others Institutions Holding EDIT

# of Institutions
247
Shares Held
57M
Call Options Held
410K
Put Options Held
394K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $168M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email